在急性骨髓性白血病中,E3泛基素结合酶Herc1调节对核糖类同类的反应
Maja Jankovic1,2, William W L Poon1,2, Cristobal Gonzales-Losada1,2
1Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Canada.
Blood advances
|August 2, 2024
概括
研究人员确定了Herc1作为影响急性髓性白血病 (AML) 细胞对细胞核酸相似物 (如cytarabine) 反应的关键因素. 失去HERC1会增加癌细胞的死亡,这表明HERC1是AML治疗的潜在治疗标.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 核类类似物如细胞氨基酸 (Ara-C) 是急性髓性白血病 (AML) 的标准诱导疗法.
- 对核糖类相似物耐药性限制了AML的治疗疗效和患者的治疗结果.
研究的目的:
- 确定调节AML中核酸相似物反应的遗传因素.
- 调查E3无素酶Herc1在AML耐药性中的作用.
主要方法:
- 在AML模型中基于CRISPR的全基因组药物基因组查.
- 使用小鼠和人类AML细胞系的体外和体内研究.
- 蛋白质组分析以确定Herc1的目标.
主要成果:
- Herc1被确定为AML中Ara-C反应的关键调节器.
- HERC1的损失通过影响细胞周期进展,增强了核类比诱导的细胞死亡.
- 脱氧化丁激酶被确定为Herc1.1的一个新目标.
- 在AML中HERC1过度表达,并与患者存活率较差有关.
结论:
- HERC1在AML细胞对核酸相似物反应中发挥着关键作用.
- HERC1是AML治疗的潜在预测生物标志物.
- HERC1代表了AML的新型治疗标.
相关概念视频
Export of Misfolded Proteins out of the ER
3.6K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.6K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


